Back to top
more

Fortress Biotech (FBIO)

(Delayed Data from NSDQ)

$1.72 USD

1.72
117,843

0.00 (0.00%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $1.72 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Fortress Biotech (FBIO) Surges 11.5%: Is This an Indication of Further Gains?

by Zacks Equity Research

Fortress Biotech (FBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Will Fortress Biotech (FBIO) Report Negative Q4 Earnings? What You Should Know

by Zacks Equity Research

Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fortress Biotech (FBIO) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Fortress Biotech (FBIO) delivered earnings and revenue surprises of 28.57% and -14.31%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Will Fortress Biotech (FBIO) Report Negative Q3 Earnings? What You Should Know

by Zacks Equity Research

Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fortress Biotech (FBIO) Enters Oversold Territory

by Zacks Equity Research

Fortress Biotech (FBIO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Fortress Biotech Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

Fortress Biotech has been struggling lately, but the selling pressure may be coming to an end soon.

Will Fortress Biotech to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor Fortress Biotech.

All You Need to Know About Fortress Biotech (FBIO) Rating Upgrade to Strong Buy

by Zacks Equity Research

Fortress Biotech (FBIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Sarepta (SRPT) Jumps: Stock Rises 8.3%

by Zacks Equity Research

Sarepta (SRPT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

    Fortress Biotech (FBIO) in Focus: Stock Moves 6.5% Higher

    by Zacks Equity Research

    Fortress Biotech (FBIO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

    Fortress Biotech (FBIO) Reports Q3 Loss, Lags Revenue Estimates

    by Zacks Equity Research

    Fortress Biotech (FBIO) delivered earnings and revenue surprises of 37.29% and -1.83%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

    Will Fortress Biotech (FBIO) Report Negative Earnings Next Week? What You Should Know

    by Zacks Equity Research

    Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Fortress Biotech (FBIO) Reports Q2 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    Fortress Biotech (FBIO) delivered earnings and revenue surprises of 25.37% and 30.46%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

      Moving Average Crossover Alert: Fortress Biotech, Inc. (FBIO)

      by Zacks Equity Research

      Moving Average Crossover Alert: Fortress Biotech, Inc. (FBIO)

        Fortress Biotech (FBIO) Shares March Higher, Can It Continue?

        by Zacks Equity Research

        As of late, it has definitely been a great time to be an investor in Fortress Biotech Inc (FBIO).

          Fortress Biotech (FBIO) Looks Good: Stock Adds 5% in Session

          by Zacks Equity Research

          Fortress Biotech, Inc. (FBIO) shares rose over 5% in the last trading session.

            Fortress Biotech (FBIO) Catches Eye: Stock Moves Up 8.3%

            by Zacks Equity Research

            Fortress Biotech, Inc. (FBIO) moved big last session, as its shares rose over 8% on the day.

              Fortress Biotech (FBIO) in Focus: Stock Moves 20.9% Higher

              by Zacks Equity Research

              Fortress Biotech, Inc. (FBIO) moved big last session, as its shares jumped almost 21% on the day.